Valeant Pharmaceuticals International Inc Company News

Old Arcived News About Valeant Pharmaceuticals International Inc

• 262 lost their jobs after Montco mail-order pharmacy closed.
• 3 Stocks Dragging The Health Care Sector Downward.
• 3 Stocks Driving The Drugs Industry Higher.
• 3 Volatile U.S. Industries to Exploit in 2016 (VRX, IBB).
• 9 Big Stocks That Doubled in 2014.
• A Valeant Tug of War.
• Ackman Accused of Insider Trading in Allergan Shareholder Suit.
• Ackman's Pershing Square off 15 percent for the year -source.
• Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive.
• Analysts' Actions -- First Solar, Transocean, United Technologies, Workday and More.
• Are Changes Underway at Valeant?.
• AZN, PRGO And VRX, 3 Drugs Stocks Pushing The Industry Lower.
• Big pharma cashes in as M&A fever sweeps sector. [at Financial Times] - It was a big year for big pharma as a succession of multibillion-dollar mergers and acquisitions swept the industry. More than $250bn of deals have been struck during 2014 - a record for the sector - as ...
• Bill Ackman's 2 Best Investments (GGP, CP).
• Bloomberg Advantage: Koon on Investors Frustration with Valeant.
• CEO Behind ‘Female Viagra’ Leaves Company After Valeant Purchase.
• Chopra Hedge Fund Said to Tumble 19% in 2015 on Valeant Loss.
• Credit homework pivotal for investors. [at Financial Times] - More than ever, undertaking credit homework matters for corporate bond investors. After years of relative tranquility, credit investors have been jolted by sudden and often unexpected volatility over the ...
• Does Valeant Have A Poland Problem?.
• FedEx Soars, Ackman Sells Mondelez (FDX, MDLZ).
• Former Drug CEO Shkreli Subpoenaed to Appear Before Congress.
• Great Stocks: Valeant Pharmaceuticals Near Buy Point.
• Hagens Berman Reminds Investors With Losses Greater Than $500,000 of December 21, 2015 Lead Plaintiff Deadline in Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc.. [GlobeNewswire] - SAN FRANCISCO, Dec. 02, 2015-- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors with over $500,000 in losses in their investments in Valeant Pharmaceuticals International, ...
• Harms of Price Hikes for Old Drugs Detailed at Senate Panel.
• Here's Why Valeant (VRX) Stock is Tumbling Further Today.
• INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Valeant Pharmaceuticals International, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 21, 2015 – VRX. [GlobeNewswire] - NEW YORK, Dec. 03, 2015-- The following statement is being issued by Levi& Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Valeant Pharmaceuticals International, ...
• J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015.
• March 17 Premarket Briefing: 10 Things You Should Know.
• March 9 Premarket Briefing: 10 Things You Should Know.
• Markets Cautious Ahead of Tomorrow's Fed Meeting (VRX, DSW).
• Medical professionals to discuss toll of Valeant, Turing drug price spikes. [Reuters] - A pediatric doctor in Alabama had to scramble to find a less expensive supply of a lifesaving drug to treat an infant who was suffering from a parasitic infection. In Utah, a hospital has been forced to change the way it stocks a drug critical to treating patients with heart conditions after the cost sky-rocketed from $440 to $2,700 a vial. The U.S. Senate's Special Committee on Aging announced last month it was launching an investigation into drug pricing and the role that mergers and acquisitions may be playing in price hikes.
• Memo From Valeant CEO Doesn't Answer Question: When Is He Back?.
• More Squawk From Jim Cramer: Sell Valeant (VRX) Stock on Accounting Irregularities.
• More Squawk From Jim Cramer: Valeant (VRX) Shares Tank on Disastrous Conference Call.
• One Reason Why Valeant (VRX) Stock Is Retreating Today.
• Put sellers see end to Valeant slide.
• Railroad wars: Crazy train. [at Financial Times] - Perhaps convoluted deal structuring, not stock picking, is Bill Ackman's true forte. Last year he formed an investment vehicle with Valeant Pharmaceuticals to facilitate a combination between Valeant and ...
• Rising Drug Costs to Be in Focus at Hearing.
• Senate investigates high drug prices.
• Senate panel focuses on toll of Valeant, Turing drug price spikes. [Reuters] - The committee also mentioned dramatic price hikes by Rodelis Therapeutics and Retrophin Inc. The Senate's Special Committee on Aging announced last month it was launching an investigation into drug pricing and the role mergers and acquisitions may be playing in price hikes. The committee is reviewing price increases for two Valeant heart drugs, Isuprel and Nitropress, and Turing's price increase on Daraprim, used to treat toxoplasmosis, a serious disease that affects AIDS patients and pregnant women and their babies.
• Senate panel leaders condemn companies for drug price hikes.
• Sequoia Fund Sued Over Valeant Pharmaceuticals Investment.
• SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on their Investment in Valeant Pharmaceuticals International, Inc. of Class Action Lawsuit and Upcoming Deadline - VRX. [Marketwired] - Pomerantz LLP announces that a class action lawsuit has been filed against Valeant Pharmaceuticals International Inc. and certain of its officers. The class action, filed in United States District Court, ...
• Shkreli Gets Snow Day as Congress Delays Hearing After Storm.
• Stock Futures Climb on Hopes for OPEC Agreement.
• Stock Futures Follow Chinese Equities Higher.
• Stocks Are Flat as Pending Home Sales Cool.
• Stocks at Session Highs as U.S. Manufacturing Improves.
• Stocks Break Higher as Crude Jumps on Saudi Support.
• Stocks Extend Gains as Crude Rises Near $38.
• Stocks Inch Higher as Fed Countdown Begins.
• Stocks Move Off Highs Despite Oil Rally.
• Stocks Move Off Lows but Crude Pressure Remains.
• Stocks Pile on Gains as Tech, Financials Lead.
• Stocks Slide as Oil Trades at Lowest Level in a Week.
• Strong Upward Pre-Market Activity For Valeant Pharmaceuticals International (VRX).
• This Is What Happens When Cheap Drugs Get Wildly Expensive.
• Today's Dead Cat Bounce Stock: Valeant Pharmaceuticals International (VRX).
• Today's Post-Market Laggard: Valeant Pharmaceuticals International (VRX).
• Top 5 Positions in John Paulson's Portfolio (AGN, VRX).
• Troubles Ahead for the Pharmaceutical Industry.
• U.S. Health Care Spending Accelerates After Historic Lows.
• Under Pressure: Eyeing Pershing Square's Holdings.
• Valeant (VRX) Stock Advanced as CEO Pearson's Health Improves.
• Valeant (VRX) Stock Climbed as Bill Ackman Increased Stake to 9%.
• Valeant (VRX) Stock Climbs After Adding New Directors, Jim Cramer: 'I Think It's Significant'.
• Valeant (VRX) Stock Drops After Settling Lawsuit With R&O Pharmacy.
• Valeant (VRX) Stock Falls on SEC Probe, Jim Cramer: 'Accounting Irregularities Equals Sell'.
• Valeant (VRX) Stock Plunges as Creditors Renegotiate Agreements.
• Valeant (VRX) Stock Plunges as Wells Fargo Sets 'Sell' Rating, Jim Cramer's Take.
• Valeant (VRX) Stock Plunges on Q4 Results, Jim Cramer: 'I Have No Idea What the Earnings Power Is'.
• Valeant (VRX) Stock Soars on Earnings Restatement, Jim Cramer: Troubles Aren't Over.
• Valeant Alert by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Fund Managers, Institutional and Large Individual Investors of Lead Plaintiff Deadline in Class Action Lawsuit against Valeant Pharmaceuticals International,. [Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind fund managers and investors that they have until December 21, 2015 to file lead plaintiff applications in a securities class action lawsuit against Valeant Pharmaceuticals International, Inc.
• Valeant Analyst: More Bad News to Come.
• Valeant Call Causes Investor Concern on Ebitda Correction.
• Valeant CEO Pearson Says He's Recovering After Complications.
• Valeant CEO Still Ill, `Star Wars' Tops $1 Billion: Sunday Wrap.
• Valeant considers selling contact lens maker.
• Valeant Executive Who Led Female Libido Pill Unit Is Out.
• Valeant Loses About 75% of Value Since August.
• Valeant Pharma (VRX) Stock Drops as CEO Returns, Earnings Release Delayed.
• Valeant Pharma (VRX) Stock Surges as CEO Pearson Meets with Top Executives.
• Valeant Pharma to Restate Earnings After Board Review.
• Valeant Pharmaceuticals (VRX) Surges After Defending Drug Price Hike.
• Valeant Pharmaceuticals International (VRX) Showing Signs Of A Dead Cat Bounce Today.
• Valeant Pharmaceuticals International (VRX): Today's Weak On High Volume Stock.
• VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials.
• VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q4 2015 Conference Call Transcript.
• Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance. [at noodls] - LAVAL, Quebec, Dec. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with ...
• Valeant Says Senior Executive's Departure Unrelated to Probe.
• Valeant Schedules, Then Cancels, Monday Call With Analysts.
• Valeant Shares Climb on Lowered 2016 Earnings Call.
• Valeant Stock Claws Back Above $100.
• Valeant's Stock Drops, Then Recovers, Following False Report Of FBI Raid.
• Valeant's Defensiveness Suggests No Better Plan: Gadfly.
• Valeant's Rise and Steep Fall: What Comes Next?.
• Valeant’s Boss Is Back: Can the CEO Save the Day, Again?.
• Visium Asset Management Is a Staunch Supporter of These 5 Healthcare Stocks.
• VRX Investor Deadline Alert: Law Offices of Howard G. Smith Reminds Valeant Pharmaceuticals, Inc. Investors Of Upcoming Lead Plaintiff Deadline. [Business Wire] - Law Offices of Howard G. Smith reminds investors of the upcoming December 21, 2015 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased Valeant Pharmaceuticals, Inc.
• Wealth Adviser Daily Briefing: Morgan Stanley Woos Credit Suisse's U.S.-Based Latin America Brokers.
• What's Next for Valeant as CEO Takes Medical Leave?.
• Why TherapeuticsMd Inc Investors Are Rejoicing Today.
• Why This Small Biotech Has Enormous Upside.
• Why Valeant (VRX) Stock Is Lower Today.
• Why Valeant Pharmaceuticals Intl Inc Is Up Today.
• Women's Sex Drive Pill Is Defended by FDA, With Caveats.
• [$$] Guess Which Funds Missed the Gain, and Pain, of Valeant. [at The Wall Street Journal] - The steep drop in Valeant’s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.